Intersect ENT

Norwest Raises Third Consecutive $1.2 Billion Fund in Five Years

Norwest Venture Partners, the 55-year-old, Palo Alto, Calif.-based venture firm, has closed its third consecutive $1.2 billion fund. The group, which employs 20 investors altogether, raised the same a

Intersect ENT Lands $30M From Norwest, Kleiner, USVP & More For Its Innovative Sinus Drug & Device Combo

In August 2011, Intersect won approval from the FDA for <a target="_blank" href="">Propel</a>, which, simply put, is a stent